What Technolution does

MGS, formerly operating as Technolution, is a vertically integrated healthcare Contract Development and Manufacturing Organization (CDMO) serving pharmaceutical, diagnostic, and medical technology (MedTech) companies globally. The firm delivers end-to-end capabilities spanning product design and development, precision tooling, custom automation, and high-volume cleanroom manufacturing of medical components and devices, with more than 250,000 square feet of cleanroom production capacity distributed across facilities in the United States, Mexico, Costa Rica, Ireland, Sweden, Germany, Belgium, Slovakia, and Denmark. The company's flagship differentiated product is the A.i.r. Platform™, a customizable autoinjector platform for pharmaceutical drug delivery applications, complemented by proprietary tooling innovations such as Hybrid Tooling and Fast-Track Tooling designed to compress development timelines for healthcare innovators.

The company monetizes primarily through project-based B2B contract manufacturing engagements, with revenue generated from design and development fees, tooling builds, automation build-outs, and high-volume production runs of plastic medical components and assemblies. Customer engagement is enterprise-driven, combining direct sales outreach, the corporate website, and participation in industry events such as ADCES to reach pharmaceutical, diagnostic, and MedTech buyers. All major production facilities carry ISO 13485 certification, with select sites also holding ISO 14001, and the firm supports FDA 21 CFR Part 820 and EU MDR approval pathways for medical devices, positioning quality systems as a core commercial differentiator.

Geographically, MGS operates a multi-continent footprint that brings production closer to customer sites, including newer sites such as the 160,000 square-foot Cartago, Costa Rica MedTech facility and the Knudsen Plast Vranov operation in Slovakia, alongside established engineering and tooling hubs in Dortmund, Germany and Anderstorp, Sweden. The firm's three primary served verticals — pharmaceutical drug delivery, diagnostics, and MedTech devices — collectively address the structural demand for outsourced precision manufacturing as healthcare OEMs increasingly rely on specialist CDMOs for complex, regulation-intensive components and delivery systems.

Name

Technolution

Legal name

MGS

Website

https://technolution-tn.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

101–250 employees

Short description

MGS (formerly Technolution) is a vertically integrated healthcare CDMO providing end-to-end design, tooling, automation, and cleanroom manufacturing services for pharmaceutical, diagnostic, and MedTech companies worldwide.

Ownership category

akta.pro rank

Product category

Medical Device Contract Manufacturing

NAICS

Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)

Keywords

• Medical device manufacturing
• Contract development manufacturing
• Autoinjector platforms
• Pharmaceutical manufacturing
• Precision injection molding

Headquarters

HQ city

Hørsholm

HQ country

Denmark

HQ region

Europe

Offices13 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Contract Manufacturing Services: End-to-end CDMO services including design & development, tooling, automation, and high-volume manufacturing of medical devices and components. Revenue generated through project-based contracts with pharmaceutical, diagnostic, and medtech companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Technolution (now operating as MGS Healthcare Manufacturing) is a healthcare Contract Development and Manufacturing Organization (CDMO) providing end-to-end services for pharmaceutical, diagnostic, and MedTech companies. Its core product is the A.i.r. Platform™, a customizable autoinjector platform for drug delivery, supported by integrated capabilities in precision tooling, custom automation, and high-precision plastic injection molding across ISO 13485-certified cleanroom facilities worldwide.

Product overview

MGS (formerly Technolution) is a Healthcare Contract Development and Manufacturing Organization (CDMO) providing vertically integrated end-to-end solutions. The company operates the A.i.r. Platform™ as its core autoinjector product, supported by service modules covering Design & Development, Tooling, Automation, and Manufacturing. The integrated value chain enables seamless transitions from early-stage product design through high-volume production of precision medical components and devices for pharmaceutical, diagnostic, and MedTech markets.

Differentiator

Problem solved

Functional benefit

Brands

• A.i.r. Platform™: Auto-Injector Platform for drug delivery devices

Products and services

• A.i.r. Platform™ An autoinjector platform enabling customizable auto-injection drug delivery devices for pharmaceutical applications. The platform provides adaptability for efficient commercialization of drug delivery products.
• Design & Development Services Comprehensive product design and development services including scoping, project management, mechanical engineering, test & verification, quality management, user experience design, sustainability engineering, usability engineering, simulation & modeling, design control, and regulatory affairs for medical device manufacturers.
• Tooling Services Precision tooling solutions including ESI & DFM, Fast-Track Tooling, Hybrid Tooling, and test & validation for medical device manufacturing. Hybrid Tooling combines multiple tooling methodologies to accelerate global healthcare product development.
• Automation Solutions Custom automation equipment technologies integrating custom assembly, part orientation, and performance validation for optimized production environments for medical device manufacturing.
• Global Manufacturing High-precision manufacturing of medical components with over 250,000 sq. ft. of cleanroom manufacturing capacity across multiple global facilities, focusing on quality, precision molding, and value-added assembly for pharmaceutical, diagnostic, and MedTech customers.

Quantifiable outcome

• Cleanroom manufacturing capacity exceeding 250,000 sq. ft.
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators2 records

Direct peers

• Ypsomed: Swiss manufacturer of injection systems including auto-injectors and pen injectors for self-medication — directly competes with MGS's A.i.r. Platform™ in pharmaceutical drug delivery devices.
• AptarGroup: Provider of drug delivery systems, consumer packaging, and active material solutions including dispensing and injection platforms for pharmaceutical applications — directly comparable in pharma drug delivery manufacturing.
• Stevanato Group: Provider of drug containment and delivery solutions including prefilled syringes, vials, and injection devices — directly competes in pharmaceutical drug delivery manufacturing with proprietary device platforms similar to MGS's A.i.r. Platform™.
• Gerresheimer: Global manufacturer of pharmaceutical packaging and drug delivery devices including glass containers and plastic systems — comparable as a healthcare-focused contract manufacturer serving pharma and diagnostics customers.
• West Pharmaceutical Services: Major supplier of drug delivery components including elastomeric closures, prefilled syringe systems, and auto-injector platforms — directly competes with MGS's drug delivery device manufacturing and autoinjector offerings for pharmaceutical customers.
• Phillips-Medisize (Molex): Large medical device CDMO offering design, development, and manufacturing of drug delivery devices and MedTech products — directly comparable end-to-end CDMO model serving pharma and MedTech customers.
• SHL Medical: Leading manufacturer of auto-injectors and pen injectors for pharmaceutical customers — directly competes with MGS's autoinjector platform in the drug delivery device market.
• Dätwyler: Provider of elastomer components and packaging solutions for pharmaceutical and medical device manufacturers — comparable as a healthcare component manufacturer serving pharma and MedTech customers.

Broad incumbents

• Recipharm: European CDMO offering contract development and manufacturing services for pharmaceutical and medical device customers — comparable as a broader CDMO serving pharma with some overlap in device manufacturing.
• Catalent: Large global CDMO serving pharma and biologics with broad services from development through commercial manufacturing — a much larger broad incumbent offering overlapping medical device and pharma manufacturing capabilities.

Market position

Strengths4 records

Weaknesses4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@mgsmfg.groupinc.5491/videos
• Facebookfacebook.com/MGS-Mfg-Group-Inc-527848147407768
• LinkedInlinkedin.com/company/mgs-mfg-group

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Technolution